Evidence map›Paper›PMID 39276159›Full record

ArticleJournal of the National Cancer Institute2025

Health insurance continuity and mortality in children, adolescents, and young adults with blood cancer.

Xu Ji, Xinyue Elyse Zhang, K Robin Yabroff, Wendy Stock, Patricia Cornwell, Shasha Bai, Ann C Mertens, Joseph Lipscomb, Sharon M Castellino

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xu JiDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0003-3025-3984
Xinyue Elyse ZhangDepartment of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, GA, USA.
K Robin YabroffSurveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.ORCID 0000-0003-0644-5572
Wendy StockDepartment of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.ORCID 0000-0002-8349-9200
Patricia CornwellAflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
Shasha BaiDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Ann C MertensDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Joseph LipscombDepartment of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Sharon M CastellinoDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Funding

Advancing novel therapeutics and translational science to close the survivorship gap in pediatric, adolescent and young adult (AYA) lymphomaR50CA285492 · NCI · EMORY UNIVERSITY · PI SHARON MARIE CASTELLINO · 2024 to 2026
$537k
Disparities in Quality Healthcare Among Childhood Cancer Survivors: Role of MedicaidK01MD018637 · NIMHD · EMORY UNIVERSITY · PI Xu Ji · 2023 to 2026
$521k
Castellino [multiple principal investigator K01MD018637CDC HHSDepartment of Public HealthLeukemia and Lymphoma SocietyLeukemia & Lymphoma Society's Equity in Access Research Program HSR9015-23NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS R50 CA285492NIH HHSNIMHD NIH HHS K01 MD018637
6 · The paper itself

Abstract

backgroundMany uninsured patients do not receive Medicaid coverage until a cancer diagnosis, potentially delaying access to care for early cancer detection and treatment. We examined the association of Medicaid enrollment timing and patterns with survival among children, adolescents, and young adults with diagnosed blood cancers, where disease onset can be acute and early detection is critical.

methodsWe identified 28 750 children, adolescents, and young adults (birth to 39 years of age) with newly diagnosed blood cancers from the 2006-2013 Surveillance, Epidemiology, and End Results program-Medicaid data. Enrollment patterns included continuous Medicaid enrollment (preceding through diagnosis), newly gained Medicaid coverage (at or shortly after diagnosis), other noncontinuous Medicaid enrollment, and private/other insurance. We assessed cumulative incidence of death from diagnosis, censoring at last follow-up, 5 years after diagnosis, or December 2018, whichever occurred first. Multivariable survival models estimated the association of insurance enrollment patterns with risk of death.

resultsOne-fourth (26.1%) of the cohort was insured by Medicaid; of these patients, 41.1% had continuous Medicaid enrollment, 34.9% had newly gained Medicaid, and 24.0% had other or noncontinuous enrollment. The cumulative incidence of all-cause death 5 year after diagnosis was highest in patients with newly gained Medicaid (30.2%, 95% confidence interval [CI] = 28.4% to 31.9%), followed by other noncontinuous enrollment (23.2%, 95% CI = 21.3% to 25.2%), continuous Medicaid enrollment (20.5%, 95% CI = 19.1% to 21.9%), and private/other insurance (11.2%, 95% CI = 10.7% to 11.7%). In multivariable models, newly gained Medicaid was associated with a higher risk of all-cause death (hazard ratio = 1.39, 95% CI = 1.27 to 1.53) and cancer-specific death (hazard ratio = 1.50, 95% CI = 1.35 to 1.68) compared with continuous Medicaid.

conclusionsContinuous Medicaid coverage is associated with survival benefits among pediatric, adolescent, and young adult patients with diagnosed blood cancers; however, fewer than half of Medicaid-insured patients have continuous coverage before diagnosis.

Indexed as

Hematologic NeoplasmsInsurance CoverageInsurance, HealthMedicaidAdolescentAdultChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMedically UninsuredSEER ProgramUnited States

Identifiers

PMID39276159
PMCPMC11807435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.